Side-by-side CRISPRi KD of vIRF3 or IRF4 affected live-cell counts in BC-3/dCas9-KRAB cells to similar degrees at all time points (Fig. 1F and G; see also Fig. S5A). The gene discussed is IRF4; the disease is breast cancer.